Polyrizon names PL-14 allergy blocker NASARIX, positioning polymer-based nasal barrier for market readiness
Find out how Polyrizon’s NASARIX branding positions the PL-14 allergy blocker for regulatory progress and future market readiness.
CornerLoc TransLoc 3D System hits key milestones in SPARTAN trial
CornerLoc has disclosed 6-month interim results from the ongoing SPARTAN Study evaluating its TransLoc 3D System, a lateral-oblique sacroiliac (SI) joint fusion platform. The data, published in the Pain Physician Journal, reported significant improvements in pain and function among enrolled patients, with no device-related or procedure-related adverse events during the evaluation period. The prospective multicenter […]
Can Avatar Medical’s glasses-free 3D imaging shift patient communication from confusion to clarity?
Avatar Medical is set to introduce Eonis Vision, a glasses-free 3D medical imaging system, at CES 2026. The product, developed in collaboration with Belgian display specialist Barco and powered by high-performance Dell hardware, is aimed at enhancing the clarity of doctor–patient communication. While the original Avatar Medical Vision software is already FDA-cleared, the updated version […]
XRlabs taps NVIDIA’s Jetson Thor and Isaac platform to rewire real-time intelligence in surgical scopes
XRlabs has disclosed it is integrating NVIDIA Jetson Thor and NVIDIA Isaac for Healthcare to develop an AI-powered retrofit system for surgical visualisation tools, aiming to deliver real-time perception, tool tracking, and intent-aware automation for neurosurgery and other minimally invasive procedures. The system is currently under early-stage clinical evaluation. Unlike traditional surgical robotics or integrated […]
CHMP backs Vueway pediatric expansion, signaling a cautious but meaningful shift in neonatal MRI contrast use
Bracco Imaging S.p.A. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion supporting the use of Vueway gadopiclenol in pediatric patients from birth. The recommendation extends an existing European Union authorization and places the macrocyclic gadolinium-based contrast agent into one of the […]
Kallisio’s Stentra system enters clinical use at Stanford, expanding precision radiation toolkit for head and neck cancer
Kallisio has begun clinical implementation of its FDA-cleared Stentra system at Stanford Health Care, marking the first reported integration of the patient-specific intraoral device into a major U.S. hospital’s workflow for head and neck cancer radiation therapy. The system, which received 510(k) clearance in January 2024, enables individualized immobilization of oral structures during intensity-modulated radiation […]
RevBio wins FDA nod to begin dental trial of TETRANITE bone adhesive
RevBio Inc. has received clearance from the United States Food and Drug Administration to begin a pilot clinical trial of TETRANITE, its regenerative bone adhesive, for dental ridge augmentation. The study will assess the product’s ability to support bone grafting procedures without the use of membranes, meshes, tacks, or screws—offering a potential simplification to a […]
Is Bebird’s EarSight Ultra X a glimpse into the future of consumer-grade otoscopy?
Bebird, the consumer-focused smart health technology firm, has officially launched the EarSight Ultra X, a next-generation ear care device featuring real-time 5G connectivity, 4K endoscopy imaging, and multiple safety enhancements tailored for family use. Positioned as a proactive wellness solution rather than a regulated diagnostic tool, the product aims to bring clinical-grade visualization into home […]
BrainSpace wins FDA nod for automated brain fluid system—what this means for ICUs
BrainSpace, a U.S.-based medical technology company, has received 510(k) clearance from the U.S. Food and Drug Administration for Intellidrop, a fully automated cerebrospinal fluid (CSF) drainage and intracranial pressure (ICP) monitoring system. The cleared indication covers ventricular or lumbar use in patients requiring external CSF drainage and continuous pressure monitoring—making it potentially relevant across a […]
Can Positron Corporation’s $2m raise unlock growth in cardiac PET-CT imaging?
Positron Corporation raises $2 million to fund PET-CT system expansion in cardiac and oncology imaging. Can it scale fast enough to compete?